Interacting Drugs |
Efavirenz, emtricitabine, and tenofovir vs Caspofungin |
Security Level |
 |
Mechanism |
Caspofungin: Inducers of Drug Clearance may decrease the serum concentration of Caspofungin. |
Management |
Consider using an increased caspofungin dose of 70 mg daily in adults (or 70 mg/m2, up to a maximum of 70 mg, daily in pediatric patients) when coadministered with known inducers of drug clearance. |
Efavirenz, emtricitabine, and tenofovir vs Caspofungin
Post Review about Efavirenz, emtricitabine, and tenofovir vs Caspofungin Click here to cancel reply.
Other Interactions of Efavirenz, emtricitabine, and tenofovir
Other Interactions of Caspofungin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.